Skin Tau Quantification as a Novel Biomarker in Huntington's Disease.
Iñigo Ruiz BarrioAnna Vázquez-OliverArnau Puig-DaviElisa Rivas-AsensioJesus Perez-PerezCristina Fernandez-VizueteAndrea Horta-BarbaGonzalo Olmedo-SauraNil Salvat-RoviraFrederic SampedroElena VacchiGiorgia MelliJavier PagonabarragaJaime KulisevskySaul-Indra Martinez-HortaPublished in: Movement disorders : official journal of the Movement Disorder Society (2024)
This study not only confirms the feasibility of skin tau quantification in Huntington's disease but also establishes its potential as a biomarker for enhancing group classification and assessing disease severity across the Huntington's disease spectrum, opening new directions in biomarker research. © 2024 International Parkinson and Movement Disorder Society.
Keyphrases